BioTE pellet therapy has documented side effects related to hormone peaks, delivery limitations, and insertion risks. As of 2026, multiple lawsuits allege informed consent failures and dosing-related harm. For patients experiencing instability, alternatives like...
Weekly testosterone injections are the most precise and adjustable alternative to pellet therapy. Unlike pellets, injections allow dose changes based on lab results and symptoms at any point—making them ideal for patients experiencing peaks, crashes, or inconsistent...
Mylan (Viatris) estradiol patches are currently backordered nationwide. The safest and most common solution is switching to another transdermal form—like gel or spray—which maintains the same safety profile. Most providers can transition you within 24–48 hours without...
TRICARE covers testosterone therapy when hypogonadism is confirmed with lab results and proper documentation. Most denials happen before approval—not because TRT is excluded, but because referrals, lab timing, or prior authorization steps are incomplete. Medically...
Kaiser Permanente covers hormone therapy, but access depends heavily on internal referrals, formulary rules, and its closed-network system. Most delays happen before prescriptions are even approved—often at the referral or internal review stage rather than at the...
Anthem covers GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro, but approval is not automatic. Prior authorization is always required, and many plans include step therapy and employer-level exclusions that can block coverage—even when the medication is...